Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linhua Zheng

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Translational Internal Medicine|August 27, 2025
Definition and validation of recompensation in patients with primary biliary cholangitis-related decompensated cirrhosis treated with ursodeoxycholic acid: Based on the BAVENO VII criteriaDawei Ding, Lina Cui, Gui Jia, et al.
Plos One|May 3, 2013
In vivo tracking and comparison of the therapeutic effects of MSCs and HSCs for liver injuryQiang Li, Xinmin Zhou, Yongquan Shi, et al.
The American Journal of Gastroenterology|March 9, 2023
Effectiveness of Fenofibrate in Treatment-Naive Patients With Primary Biliary Cholangitis: A Randomized Clinical TrialYansheng Liu, Guanya Guo, Linhua Zheng, et al.
Hepatology International|December 11, 2024
Low-risk individuals with primary biliary cholangitis and significant liver stiffness: prognosis and treatmentDawei Ding, Yinan Hu, Gui Jia, et al.
Gastroenterologia Y Hepatologia|January 12, 2023
Fenofibrate normalizes alkaline phosphatase and improves long-term outcomes in patients with advanced primary biliary cholangitis refractory to ursodeoxycholic acidDawei Ding, Pengwei Ren, Guanya Guo, et al.
Plos One|September 18, 2012
Dynamic microRNA profiles of hepatic differentiated human umbilical cord lining-derived mesenchymal stem cellsLina Cui, Xinmin Zhou, Jinge Li, et al.
Stem Cell Research & Therapy|January 3, 2024
Identifying optimal candidates for autologous peripheral blood stem cell therapy in patients with decompensated liver cirrhosis: a prognostic scoring systemSiyuan Tian, Guanya Guo, Xia Zhou, et al.
Hepatology International|October 30, 2022
Prediction and evaluation of high-risk patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy: an early criterionChunmei Yang, Guanya Guo, Bo Li, et al.
Hepatology International|September 19, 2023
Prognostic significance of liver stiffness in patients with primary biliary cholangitis: validation of Baveno VII criteriaDawei Ding, Guanya Guo, Lina Cui, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2024
Hypercholesterolemia Is Associated With Dysregulation of Lipid Metabolism and Poor Prognosis in Primary Biliary CholangitisLinhua Zheng, Siyuan Tian, Chunmei Yang, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Translational Internal Medicine|August 27, 2025
Definition and validation of recompensation in patients with primary biliary cholangitis-related decompensated cirrhosis treated with ursodeoxycholic acid: Based on the BAVENO VII criteriaDawei Ding, Lina Cui, Gui Jia, et al.
Plos One|May 3, 2013
In vivo tracking and comparison of the therapeutic effects of MSCs and HSCs for liver injuryQiang Li, Xinmin Zhou, Yongquan Shi, et al.
The American Journal of Gastroenterology|March 9, 2023
Effectiveness of Fenofibrate in Treatment-Naive Patients With Primary Biliary Cholangitis: A Randomized Clinical TrialYansheng Liu, Guanya Guo, Linhua Zheng, et al.
Hepatology International|December 11, 2024
Low-risk individuals with primary biliary cholangitis and significant liver stiffness: prognosis and treatmentDawei Ding, Yinan Hu, Gui Jia, et al.
Gastroenterologia Y Hepatologia|January 12, 2023
Fenofibrate normalizes alkaline phosphatase and improves long-term outcomes in patients with advanced primary biliary cholangitis refractory to ursodeoxycholic acidDawei Ding, Pengwei Ren, Guanya Guo, et al.
Plos One|September 18, 2012
Dynamic microRNA profiles of hepatic differentiated human umbilical cord lining-derived mesenchymal stem cellsLina Cui, Xinmin Zhou, Jinge Li, et al.
Stem Cell Research & Therapy|January 3, 2024
Identifying optimal candidates for autologous peripheral blood stem cell therapy in patients with decompensated liver cirrhosis: a prognostic scoring systemSiyuan Tian, Guanya Guo, Xia Zhou, et al.
Hepatology International|October 30, 2022
Prediction and evaluation of high-risk patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy: an early criterionChunmei Yang, Guanya Guo, Bo Li, et al.
Hepatology International|September 19, 2023
Prognostic significance of liver stiffness in patients with primary biliary cholangitis: validation of Baveno VII criteriaDawei Ding, Guanya Guo, Lina Cui, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2024
Hypercholesterolemia Is Associated With Dysregulation of Lipid Metabolism and Poor Prognosis in Primary Biliary CholangitisLinhua Zheng, Siyuan Tian, Chunmei Yang, et al.
Pageof 3